IP Verse

Inhalation Composition Containing Aclidinium For Treatment Of Asthma And Chronic Obstructive Pulmonary Disease

Patent No. EP2265257 (titled "Inhalation Composition Containing Aclidinium For Treatment Of Asthma And Chronic Obstructive Pulmonary Disease") was filed by Almirall on Mar 13, 2009. The application was issued on Oct 25, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKMay 12, 2016FRKELLY
HEXALMay 6, 2016TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2265257

ALMIRALL
Application Number
EP09719213A
Filing Date
Mar 13, 2009
Status
Patent Maintained As Amended
Sep 22, 2023
Publication Date
Oct 25, 2023
External Links
Slate, Register , Google Patents